Article
Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area.
European journal of cancer (Oxford, England : 1990) - 1 Oct 2017
Schreuder K, Kuijer A, Rutgers E J Th, Smorenburg C H, van Dalen Th, Siesling S
Abstract excerpt
PURPOSE: In Dutch guidelines, gene expression profiles (GEP) are indicated in estrogen receptor positive early breast cancer patients in whom benefit of chemotherapy (CT) is uncertain based on traditional prognostic factors alone. Aim of the present study is to assess the use and impact of GEP on administration of adjuvant CT in breast cancer patients who have according to national guidelines a clear indication...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
